Cytex Therapeutics, Inc.
PrivateLast Round
Series A
Jan 30, 2025
Est. Valuation
$18.67M
Total Funding Raised
$3.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytex Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Debt round in January 2024.
Cytex Therapeutics, Inc. is a medical device company that develops regenerative orthopedic implants designed to restore cartilage and bone in damaged or diseased joints.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytex Therapeutics, Inc. Comparables
Compare Cytex Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orthox | 85% | |
| Nanochon | 84% | |
| Sparta Biomedical | 82% |
For institutional investors. Book with your work email.
Cytex Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2025 | ||||
| Debt | Jan 1, 2024 | ||||
| Series B | Jan 24, 2023 | ||||
| Debt | Jun 1, 2022 | ||||
| Grant | Jun 11, 2007 |
For institutional investors. Book with your work email.
Cytex Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NC IDEA | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| North Carolina Biotechnology Center | Debt |
| National Institutes of Health (NIH) | Grant |
| Liquid 2 Ventures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 67% MoM, reaching 2.3K.
- Mar 3, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
Cytex Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytex Therapeutics, Inc.'s valuation, stock price, and market status.
Is Cytex Therapeutics, Inc. a public or private company?
Cytex Therapeutics, Inc. is a private company.
What is the current stock price of Cytex Therapeutics, Inc.?
Cytex Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Cytex Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytex Therapeutics, Inc. worth (valuation)?
Cytex Therapeutics, Inc.'s valuation is estimated at $18.7M based on funding round data.
Can I buy Cytex Therapeutics, Inc. stock?
Cytex Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytex Therapeutics, Inc.'s last funding round?
Cytex Therapeutics, Inc.'s most recent funding round was Series A on January 30, 2025.
Who are the main investors in Cytex Therapeutics, Inc.?
Key investors in Cytex Therapeutics, Inc. include NC IDEA, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH RADx, National Institute on Aging, North Carolina Biotechnology Center.
Will Cytex Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Cytex Therapeutics, Inc..
How can I track Cytex Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cytex Therapeutics, Inc.'s shares on secondary markets.